FDA approves generic version of Lyrica to cut treatment costs Dr. Kamal Kant Kohli Kohli23 July 2019 7:05 PM ISTFood and drug administration(FDA) has approved generic version of Lyrica to cut treatment costs.The U.S. Food and Drug Administration approved...
MS risk in Vitamin D deficiency due to environmental factors and not due to genetic predisposition Dr. Kamal Kant Kohli Kohli23 July 2019 9:05 AM ISTVitamin D deficiency increases multiple sclerosis(MS) risk due to environmental factors, not a genetic predisposition, suggests a new study.A new...
Exercise prevents brain damage and cognitive decline in Alzheimer's disease: JAMA Dr. Kamal Kant Kohli Kohli19 July 2019 7:15 PM ISTResearchers from Massachusetts General Hospital (MGH) have found that higher levels of daily exercise or physical activity may protect against the...
FDA clears laser for chronic low back pain for first time Dr. Kamal Kant Kohli Kohli18 July 2019 7:20 PM ISTFDA grants first market clearance to laser for chronic low back pain.The Food and drug administration has granted approval to FX 635, a low-level...
Clinical trial to find Pioglitazone role in reducing stress related alcohol use Dr. Kamal Kant Kohli Kohli18 July 2019 7:10 PM ISTA Clinical trial has been launched to find whether Pioglitazone reduces stress related alcohol use.Researchers at The University of Texas Health...
Even single bout of exercise alleviates symptoms of ADHD, finds study Dr. Kamal Kant Kohli Kohli18 July 2019 9:03 AM ISTEven a single bout of exercise alleviates symptoms of ADHD, finds new study.According to a new study by University of Georgia researchers, exercise...
FDA approves first rosuvastin powder for patients with difficulty in swallowing Dr. Kamal Kant Kohli Kohli18 July 2019 9:00 AM ISTFDA approves first and only rosuvastin powder for patients with difficulty in swallowing.The Food and Drug Administration (FDA) has approved a new...
FDA approves first ever contrast agent for cardiac MRI Dr. Kamal Kant Kohli Kohli17 July 2019 7:05 PM ISTFDA approves first ever contrast agent for cardiac MRI.The U.S. Food and Drug Administration (FDA) has approved Gadavist®(gadobutrol) injection for...
FDA approves treatment for complicated urinary tract and abdominal infections Dr. Kamal Kant Kohli Kohli17 July 2019 9:03 AM ISTFDA approves treatment for complicated urinary tract and abdominal infections.The U.S. Food and Drug Administration has approved Recarbrio (imipenem,...
Dual drug delivery system may make heart stents safer Dr. Kamal Kant Kohli Kohli16 July 2019 8:28 PM ISTMedicated stents are widely used to unblock heart arteries. While the drug prevents the growth of muscle cells around the stent, it, however, retards...
Compared to traditional cannabis, Synthetic cannabinoids more likely to cause seizures, coma in kids Dr. Kamal Kant Kohli Kohli16 July 2019 7:25 PM ISTA new study has found that Teens using synthetic cannabinoids (SCs) were more likely to experience seizures and coma compared to those using...
Just cutting 300 calories daily is all it takes to reduce CVD risk even in lean people, finds Clinical trial Dr. Kamal Kant Kohli Kohli13 July 2019 9:01 AM ISTJust cutting 300 calories daily is all it takes to reduce the risk of cardiovascular disease even in lean people, finds Clinical trial.New data from a...
